icon-    folder.gif   Conference Reports for NATAP  
  20th Conference on Retroviruses and
Opportunistic Infections
Atlanta, GA March 3 - 6, 2013
Back grey_arrow_rt.gif
Similar Cognition Outcomes After 24 Weeks for Tenofovir/FTC + Atazanavir/r (ATV/r)-Experienced HIV+ Subjects or Those Simplifying to Abacavir/3TC+ATV
  Reported by Jules Levin
CROI 2013 Atlanta March 3-6
Kevin Robertson,1* Paul Maruff,2 David Wohl,1 Laveeza Bhatti,3 Catherine Small,4 Howard Edelstein,5 Henry Zhao,6 David Margolis,6 Lisa Ross,6 Mark Shaefer,7 for the ASSURE (EPZ113734) Study Team
1University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2Cogstate Ltd, Melbourne, Australia; 3AIDS HealthCare Foundation, Beverly Hills, CA, USA; 4NY Medical College, Valhalla, NY, USA; 5Alameda County Medical Center, Oakland, CA, USA; 6GlaxoSmithKline, Research Triangle Park, NC, USA; 7ViiV HealthCare, Research Triangle Park, NC, USA
from Jules: Wednesday today at CROI is a Late Breaker poster finding dolutegravir enters the brain.